David E. I. Pyott, Director at Edwards Lifesciences Corp (EW), bought 3,000 shares at $62.95 ($189K) on 2013-05-01, disclosed to the SEC on 2013-05-01.
Seasonal purchase ($189k) by Director — this insider has traded EW in May in at least three consecutive prior years. Pattern-driven, low signal.
Negative factors outweigh the positive ones.
| Filing → |
| ALNY | SELL | 2024-06-26 | $7.2M | — | Filing → |
| BMRN | BUY | 2020-09-01 | $1.0M | — | Filing → |
| AVY | SELL | 2020-02-05 | $1.3M | — | Filing → |